0001715819 false 0001715819 2023-04-20 2023-04-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 20, 2023

 

 

ELECTROMEDICAL TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware Commission File Number 82-2619815
(State or other jurisdiction of
incorporation or organization)		 000-56192 (I.R.S. Employer
Identification Number)

 

16561 N. 92nd Street, Ste. 101

Scottsdale, AZ 85260

 (Address of Principal Executive Offices and Zip Code) 

 

888-880-7888

(Issuer's telephone number)

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbols Name of Exchange on Which Registered
COMMON EMED NONE

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Section 7 - Regulation FD

 

Item 7.01 Regulation FD Disclosure.

 

On March 21, 2023, the Registrant filed Form 8-K disclosing its sale of real property located at 16561 N. 92nd Street, Ste. 101, Scottsdale, AZ 85260. The purchaser was Care National Healthcare Services, Inc. ("Care National"). Care National paid a purchase price of $2,000,000.00, with net proceeds to the Registrant of $1,358,710.56.

 

Since the Registrant's receipt of net proceeds, the Registrant expended the following sums related to its previously announced and disclosed "Wellness Pro Plus Infinity" product: $290,000 on research and development, $150,000 in testing and tooling, and $210,000 in purchasing inventory components.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated April 20, 2023 
   
ELECTROMEDICAL TECHNOLOGIES, INC. 
   
By:/s/ Matthew Wolfson 
Matthew Wolfson 
Chief Executive Officer 
(Principal Executive Officer) 

 

 

ElectroMedical Technolog... (PK) (USOTC:EMED)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024 Haga Click aquí para más Gráficas ElectroMedical Technolog... (PK).
ElectroMedical Technolog... (PK) (USOTC:EMED)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024 Haga Click aquí para más Gráficas ElectroMedical Technolog... (PK).